Genmab | GEN - Market Capitalization


Genmab reported DKK100.57B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
argenx SE USD 44.38B 7.45B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Demant DKK 46.01B 10.48B Dec/2025
Exelixis USD 10.89B 857M Mar/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Insmed USD 35.3B 1.82B Mar/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025